In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Soleno Therapeutics Inc.

www.capnia.com

Latest From Soleno Therapeutics Inc.

Deals Shaping The Medical Industry, April 2017

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in March 2017.

Deals BioPharmaceutical

Capina, Essentialis Merger To Create Rare Disease Firm

The combined company would advance a diazoxide choline controlled-release daily pill for treating patients with Prader-Willi syndrome through pivotal Phase II/III clinical trialing.

M & A Metabolic Disorders

Medtech Execs On The Move, May 2016

Recent executive-level company changes and promotions in the medical device and diagnostics industries.

Execs On The Move, May 2016

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Diagnostic Equipment & Supplies
  • Pharmaceuticals
    • Drug Delivery
      • Nasal
  • Therapeutic Areas
  • Immune Disorders
  • Neurology, Nervous System
  • Respiratory, Pulmonary
  • Alias(es)
  • Capnia Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Soleno Therapeutics Inc.
  • Senior Management
  • Anish Bhatnagar, MD, CEO
    David O'Toole, CFO
    Anthony Wondka, VP, R&D
  • Contact Info
  • Soleno Therapeutics Inc.
    Phone: (650) 213-8444
    1235 Radio Rd., Ste. 110
    Redwood City, CA 94065
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register